
Overview
Mitsuhiro Tozaki practices practicing medicine in Tokyo, Japan.
Tozaki is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Breast Cancer, BRCA Positive Breast Cancer, and Mastectomy.
They are actively involved in clinical research, co-authoring 92 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mitsuhiro Tozaki
Is Mitsuhiro Tozaki a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Mitsuhiro Tozaki is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mitsuhiro Tozaki participate in research or clinical trials?
Yes. Mitsuhiro Tozaki has published 92 articles and abstracts on conditions like Breast Cancer. You can view a list of Mitsuhiro Tozaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerTozaki isAdvanced. Learn about Breast Cancer.
- Experienced
- BRCA Positive Breast CancerTozaki isExperienced. Learn about BRCA Positive Breast Cancer.
- MastectomyTozaki isExperienced. Learn about Mastectomy.